Six-Day Countdown: Spotlight on China's Innovative Medical Industrial Parks – 2020 Future Healthcare 100: Industrial Park Edition

China’s healthcare industry is in a period of rapid development, with innovative models continually emerging and new players entering the market. As the number of participants grows and the cluster effect of leading life science industrial parks expands, competition among local industrial parks will continue to intensify, thereby accelerating the reshuffling of the existing landscape.

Beyond the clustering effects already established in leading parks such as Zhangjiang Hi-Tech Park and Zhongguancun Science Park, we have observed the gradual emergence of a cohort of medical industrial parks with significant development and investment potential. These parks are driven by innovation and demonstrate notable strengths in industrial positioning, product development, technology, business models, distribution channels, branding, service models, policy frameworks, and financial innovation.

Through the solicitation and survey of life science industrial parks, we aim to focus on in-depth analysis and comprehensively decode the landscape of innovative industrial parks, explore effective development pathways, identify exemplary models, and provide decision-making support for local governments in investment promotion, investment institutions in capital allocation, and enterprises in site selection.

In light of this, the 2020 Future Healthcare Top 100 list has specially added the Future Healthcare Top 100 · Industrial Park List. This ranking will cover more than 100 life science industrial parks.

This award is primarily targeted at innovative industrial parks in the life sciences sector, based onIndustrial Agglomeration Efficiency, Sci-Tech Innovation Capability, and Service Capabilityand other dimensions, for comprehensive comparisonInnovation Pathways for Industrial Parks, selectCultivating Excellence in Niche Sectors, Delivering Distinctive Industry Services, and Providing a Comprehensive and Meticulous Service Systemsuch as featured industrial parks, are recommended as industry benchmarks.

2. Top 100 Future Healthcare · Outstanding Park Operator

This award primarily targets the enhancement of operational capabilities within life science industrial parks and among their operators, aiming to discoverOutstanding Industrial Operational Capabilities and Significant Growth Potentialof excellent industrial parks, summarize the core value elements of their successful operational services, promote the development experience of operational services for excellent industrial parks, and provide references for industry development.

3. Top 100 Future Healthcare · Park Innovative Financial Service Institution

This award primarily evaluates the development of financial service channels within the industrial park.

1. Received an on-site award at the “2020 China Innovative Medical Industrial Park Symposium”

Based on an assessment of participation levels and the effectiveness of recommendations, we will selectively invite parks, government bodies, and institutions serving as strategic support partners to attend the “2020 Regional Healthcare Industry Innovation Forum,” scheduled for December (tentative) in Chongqing, where the awards ceremony for the rankings will be held on-site.

2. Priority docking for enterprise implementation needs

Innovative enterprises from VCBeat’s channels with implementation needs will be given priority in matching and connecting with the listed industrial parks.

3. Outstanding strategic support organizations will be granted five tickets to the 2020 Future Healthcare 100 Conference, with additional opportunities to be invited as speakers.

The Future Healthcare Top 100 Conference is the largest and most information-rich summit integrating industry and capital within China’s healthcare innovation sector. Having been successfully held for four editions, it has attracted over 10,000 registered attendees, 41% of whom are from senior management and decision-making levels. Nearly 3,000 enterprises have participated, including the Top 100 most valued companies in China’s healthcare innovation landscape, as well as Fortune Global 500 companies, multinational corporations, and listed companies. It is also one of the annual must-attend events for more than 800 angel investors, venture capital (VC) firms, private equity (PE) firms, investment banks, strategic investors, and securities firms.

Deadline: December 6, 2020

For inquiries or industry exchanges, please feel free to contact us.

Fang Qiuxue

15208495425 (WeChat ID same as phone number)